Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Baber

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Minerva Cardioangiologica|May 17, 2014
Current developments in dual antiplatelet therapy after stentingD Giacoppo, U Baber, R Mehran
Arthritis and Rheumatism|May 14, 1999
Immunization of mice with human 60-kd Ro peptides results in epitope spreading if the peptides are highly homologous between human and mouseR H Scofield, K M Kaufman, U Baber, et al.
Kidney International|December 14, 2007
Non-traditional risk factors predict coronary calcification in chronic kidney disease in a population-based cohortU Baber, J A de Lemos, A Khera, et al.
Clinical Pharmacology and Therapeutics|May 24, 2016
Exome sequencing of extreme clopidogrel response phenotypes identifies B4GALT2 as a determinant of on-treatment platelet reactivityS A Scott, J-P Collet, U Baber, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Minerva Cardioangiologica|May 17, 2014
Current developments in dual antiplatelet therapy after stentingD Giacoppo, U Baber, R Mehran
Arthritis and Rheumatism|May 14, 1999
Immunization of mice with human 60-kd Ro peptides results in epitope spreading if the peptides are highly homologous between human and mouseR H Scofield, K M Kaufman, U Baber, et al.
Kidney International|December 14, 2007
Non-traditional risk factors predict coronary calcification in chronic kidney disease in a population-based cohortU Baber, J A de Lemos, A Khera, et al.
Clinical Pharmacology and Therapeutics|May 24, 2016
Exome sequencing of extreme clopidogrel response phenotypes identifies B4GALT2 as a determinant of on-treatment platelet reactivityS A Scott, J-P Collet, U Baber, et al.
Pageof 1